Clinical trial
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain…
NCT00390806 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00390806 |
|---|---|
| Title | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer |
| Official title | A Randomized, Phase III, Open-Label Study of Oral Topotecan Plus Whole-Brain Radiation Therapy (WBRT) Compared With WBRT Alone in Patients With Brain Metastases From Non-Small Cell Lung Cancer |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer, Non-Small Cell |
| Intervention type | Drug, Radiation |
| Interventions | HYCAMTIN, oral capsules, Radiation |
| Enrollment | 472 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2012 |
| Completion | Sep 1, 2013 |
| First posted | Oct 20, 2006 |
| Last update posted | Jan 20, 2014 |
| Countries | Canada, Hungary, Poland, Russia, Slovakia, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: